Dr. Aline Mack , PharmD
Pharmacist • Burbank, CA
310 N Clybourn Ave
Burbank, CA 915053701
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on January 5, 2007; this date does not establish years in practice.
-
Published CMS data list 754 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Glipizide — 125 prescription fills, including refills.
- Humulin N Kwikpen (Insulin Nph Human Isophane) — 96 prescription fills, including refills.
- Nano 2nd Gen Pen Needle (Pen Needle, Diabetic) — 60 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 21 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 90% of clinicians listed under Pharmacist in Burbank, CA (2024, 12 clinicians with data). Median for this group: 95. Middle half: 66 to 119.
More Part D prescriptions than 90% of clinicians listed under Pharmacist in California (2024, 4,002 clinicians with data). Median for this group: 64. Middle half: 32 to 128.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 883 in 2020 to 754 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
310 N Clybourn Ave
Burbank, CA 915053701
What Public CMS Data Show
Pharmacist: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
2,214 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$81,439 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
NPI first issued
2007
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Burbank and California
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under Pharmacist in Burbank, CA (2024, 12 clinicians with data). Median for this group: 95. Middle half: 66 to 119.
More Part D prescriptions than 90% of clinicians listed under Pharmacist in California (2024, 4,002 clinicians with data). Median for this group: 64. Middle half: 32 to 128.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Pharmacist in Burbank, CA (2024, 12 clinicians with data). Median for this group: $20,880. Middle half: $14,286 to $24,494.
A higher Part D drug cost than 90% of clinicians listed under Pharmacist in California (2024, 4,002 clinicians with data). Median for this group: $13,282. Middle half: $6,203 to $25,065.
137 active clinicians are listed under Pharmacist with a practice address in Burbank, CA (32,552 in California).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Burbank
0% of these 137 clinicians have the CMS telehealth indicator.
0% of these 137 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 15% from 883 in 2020 to 754 in 2024.
- 2020: 883
- 2021: 899
- 2022: 963
- 2023: 1,081
- 2024: 754
-
30-day fills
30-day fills decreased 14% from 2,572 in 2020 to 2,214 in 2024.
- 2020: 2,572
- 2021: 2,626
- 2022: 2,866
- 2023: 3,262
- 2024: 2,214
-
Part D drug cost
Part D drug cost increased 38% from $58,833 in 2020 to $81,439 in 2024.
- 2020: $58,833
- 2021: $58,457
- 2022: $73,817
- 2023: $111,853
- 2024: $81,439
Sources: CMS Medicare Part D Prescribers (2024), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Glipizide | Glipizide | 125 | 12,050 | $1,514.37 | 64 |
| Humulin N Kwikpen | Insulin Nph Human Isophane | 96 | 7,119 | $19,957.65 | 42 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 60 | 4,830 | $1,158.39 | 26 |
| Metformin Hcl Er | Metformin Hcl | 52 | 4,950 | $527.59 | 31 |
| Metformin Hcl | Metformin Hcl | 43 | 4,150 | $650.13 | 28 |
| Jardiance | Empagliflozin | 43 | 4,090 | $23,719.74 | 26 |
| Humulin N | Insulin Nph Human Isophane | 39 | 3,503 | $6,125.97 | 23 |
| Atorvastatin Calcium | Atorvastatin Calcium | 37 | 3,700 | $469.81 | 20 |
| Losartan Potassium | Losartan Potassium | 33 | 3,150 | $531.79 | 17 |
| Amlodipine Besylate | Amlodipine Besylate | 26 | 2,600 | $323.43 | 19 |
| Humulin R | Insulin Regular, Human | 26 | 1,502 | $2,128.11 | 17 |
| Glipizide Er | Glipizide | 24 | 2,330 | $681.56 | 11 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 22 | 2,200 | $256.74 | 12 |
| Lisinopril | Lisinopril | 21 | 2,016 | $278.42 | 13 |
| Ozempic | Semaglutide | 21 | 798 | $20,163.19 | — |
| Pioglitazone Hcl | Pioglitazone Hcl | 18 | 1,800 | $210.06 | — |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 17 | 1,540 | $601.91 | 11 |
| Veo Insulin Syringe | Syrge-Ndl,ins 0.3 Ml Half Mark | 16 | 870 | $279.49 | — |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 13 | 1,188 | $1,587.17 | — |
| Atenolol | Atenolol | 11 | 960 | $169.72 | — |
| Hydralazine Hcl | Hydralazine Hcl | 11 | 1,032 | $103.84 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 183500000X
An individual licensed by the appropriate state regulatory agency to engage in the practice of pharmacy. The practice of pharmacy includes, but is not limited to, assessment, interpretation, evaluation, and implementation, initiation, monitoring or modification of medication and or medical orders; the compounding or dispensing of medication and or medical orders; participation in drug and device procurement, storage, and selection; drug administration; drug regimen reviews; drug or drug-related research; provision of patient education and the provision of those acts or services necessary to provide medication therapy management services in all areas of patient care.
Career & Practice History
NPI enumerated January 05, 2007.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Pharmacists in Burbank
- Gwyneth Voong, PHARMACIST
- Dr. Andranik Harutyunyan, PharmD
- Dr. Angineh Parseghian, PharmD
- Erlinda Alcala, RPH
- Carol Dixon
- Dr. Hakop Aladzhadzhyan, PharmD
Mailing Address
310 N Clybourn Ave
Burbank, CA 915053701